Dr. Ravi Kumar is a board-certified neurosurgeon who left the operating room to explore the questions that matter most about your health.
Listen to the PodcastEvery week, I cut through the noise of health headlines and marketing claims to bring you what the research actually says. No dogma, no agenda, just an honest look at the science that shapes how you live, heal, and thrive.
Most people have never heard of reactive hypoglycemia, and neither have a lot of physicians, yet it may affect up to half the population and it is one of the earliest warning signs on the road to prediabetes and diabetes. Dr. Ravi Kumar sits down with Dr. Keith Berkowitz, who worked alongside Dr. Robert Atkins in the late 1990s and carried that whole way of practicing medicine forward after Atkins died. They unpack what reactive hypoglycemia actually is, why a blood sugar crash a few hours after eating leaves you tired, foggy, anxious, and hangry, why it is the cortisol response and not the low glucose that produces the symptoms, and how insulin resistance builds for 20 years before a standard lab ever looks abnormal. Along the way: the low fat era, the sugar industry's role in villainizing fat and eggs, the gut microbiome, continuous glucose monitors, and why the tools to catch this early finally exist.
View full episode →
Dr. Ravi Kumar is a board-certified neurosurgeon and assistant professor of neurosurgery at the University of North Carolina. After years in the operating room, a transformative sabbatical in India changed how he saw medicine forever.
Now, through The Dr. Kumar Discovery, he explores the intersection of modern science, traditional wisdom, and the questions most doctors never think to ask.
Read the full story
The Senate HELP Committee voted 12-10 to advance the Childhood Diabetes Reduction Act, which would put warning labels on ultra-processed foods and ban junk food ads aimed at children.
A new JAMA Network Open study of 133,606 matched adults found a 21% lower three-year fracture risk on GLP-1 drugs overall, but a higher risk in the growing group of users who do not have type 2 diabetes.
The FDA's Pharmacy Compounding Advisory Committee voted on July 23, 2026 to recommend adding BPC-157, KPV, TB-500 and MOTS-c to the Section 503A Bulks List, rejecting the agency's own reviewers, who had proposed that none of them be included.
★★★★★"So glad I found this podcast. Dr. Kumar doesn't want you to just mask symptoms, he wants you to understand root causes and help you truly heal. He is the best of both worlds - he shares a wealth of modern medical knowledge, but also empowers the listeners to take personal responsibility for their health."
cngggggggggg
★★★★★"I love this podcast! It's smart and covers the science in very accessible ways. After each episode I feel empowered to make some changes in my life. Thanks, Dr. Kumar!"
Dr Kumar Review
★★★★★"Dr Kumar's podcasts have been such a great find! As an OR nurse I have worked with neurosurgeons for years. I found the podcasts to be informative, easy to follow and just the right length."
NRRN66
Reviews from Apple Podcasts